2Weber WA,Wester HJ,Grosu AL,et al.O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-^11C]methionine uptake in brain tumours:initial results of a comparative study[J].Eur J Nucl Med,2000,27(5):542-549.
5Yang DJ,Wallace S,Cherif A,et al.Development of F-18-labeled Fluoroerythronitroimidazole as a PET Agent for Imaging Tumor Hypoxia[J].Radiology,1995,194(3):795-800.
1Ahuja V, Coleman RE, Herndon J, et al.Prognostic significance of FDG-PET imaging in patients with non-small cell lung cancer. Cancer, 1998, 83: 918-924.
2Kubota K, Tada M, Yamada S, et al. Comparison of the distribution of 18F-fluoromisonidazole, deoxyglucose and methionine in tumour tissue. Eur J Nucl Med, 1999, 26: 750-757.
3Koh WJ, Bergman KS, Rasey JS, et al. Evaluation of oxygenation status during fractionated radiotherapy in human non-small cell lung cancers using 18F-fluoromisonidazole positron emission tomography. Int J Radiat Oncol Biol Phys,1998, 33: 391-398.
4Rasey JS, Koh WJ, Evans ML, et al. Quantifying regional hypoxia in human tumors with positron emission tomography of 18F-fluoromisonidazole: a pretherapy study of 37 patients.Int J Radiat Oncol Biol Phys, 1996, 36: 417-428.
5Lehtio K, Oikonen V, Nyman S, et al. Quantifying tumor hypoxia with 18F-fluoroerythronitroimidazole (18 F-FETNIM) and PET using the tumor to plasma ratio. Eur J Nucl Med Mol Imaging, 2003, 30: 101-108.
6Takahashi N, Fujibayashi Y, Yonekura Y, et al.Evaluation of 62Cu labeled diacetyl-bis ( N-4-methylthiosemicarbazone) as a hypoxic tissue tracer in patients with lung cancer. Ann Nucl Med, 2000, 14: 323-328.
7Siim BG, Laux WT, Rutland MD, et al. Scintigraphic imaging of the hypoxia marker 99 Tcm-labeled 2,2'- ( 1,4-diaminobutane ) bis (2-methyl-3-butanone) dioxime (99Tcm labeled HL91; Prognox): non-invasive detection of tumor response to the antivascular agent 5,6-dimethylxanthenone-4-acetic acid. Cancer Res, 2000, 60: 4582-4588.
8Chao KS, Bosch WR, Mutic S, et al. A novel approach to overcome hypoxic tumor resistance:Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys, 2001,49: 1171-1182.
9Haberkom U, Strauss LG, Dimitrakopoulou A,et al. PET studies for fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. J Nucl Med,2001, 32:1485-1490.
10Erdi YE, Macapinlac H, Rosenzweig KE, et al.Use of PET to monitor the response of lung cancer to radiation treatment. Eur J Nucl Med,2000, 27: 861-866.
3Mok JS, Marshall JN, Chart M, et al. Percutanecous embolization to control intractable epistaxis in nasopharyngeal carcinoma [ J ]. Head Nek, 1999,21 : 211 - 216.
5Quinn MA, Benedet JL, Odicino F, et al. Carcinoma of the cervix uteri FIGO 26th Annual Report on the results of treatment in gyneco- logical cancer[ J]. Int J Gynaecol Obstet, 2006, 95 (Suppl 1 ) : S43-103.
6Newman MJ. Problem based learning: an introduction and overview of the key features of the approach[ J]. J Vet Med Educ, 2005, 32 (1) :12-20.
